Goitre Market to Reach USD 9.74 Billion by 2034

Pune, India - December 2025 - The global Goitre Market, valued at USD 5.88 billion in 2024, is projected to reach USD 9.74 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing awareness of thyroid health, rising incidence of autoimmune thyroid diseases, and widespread implementation of iodine supplementation programs are fueling sustained market growth.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72019

Market Summary
The Goitre Market is expanding as global thyroid disorders become increasingly common. Goitre-an abnormal enlargement of the thyroid gland-occurs due to iodine deficiency, autoimmune thyroid diseases (Graves' disease, Hashimoto's thyroiditis), multinodular goitre, congenital abnormalities, and environmental & dietary influences.

Iodine deficiency remains a major driver in many developing regions, despite strong global progress in universal salt iodization (USI). Meanwhile, autoimmune thyroid conditions are rising sharply in developed regions due to genetic predisposition, dietary factors, and environmental triggers.

Diagnosis is improving with thyroid function tests (TSH, T3, T4), thyroid antibodies, ultrasound, radionuclide scanning, and fine-needle aspiration cytology (FNAC). Treatment options include levothyroxine therapy, antithyroid drugs, iodine supplementation, and in severe or complicated cases, thyroidectomy or radioiodine therapy.

North America and Europe lead in autoimmune goitre management, while Asia-Pacific is the fastest-growing region due to high population exposure, dietary patterns, and rising healthcare access.

Key Takeaways
• 2024 Market Size: USD 5.88 Billion
• 2034 Forecast: USD 9.74 Billion
• CAGR: 5.2% (2025-2034)**
• Iodine deficiency still drives large patient pools in developing regions
• Autoimmune thyroid disorders increasing in developed markets
• Asia-Pacific expected to see highest growth in screening & treatment uptake

Market Drivers
• Expansion of iodine fortification & nutritional programs
• Rising prevalence of Hashimoto's disease and Graves' disease
• Growing use of ultrasound & advanced thyroid imaging
• Increasing adoption of levothyroxine and modern antithyroid therapies
• Improved awareness of thyroid health through national screening campaigns

Segmentation Snapshot
By Disease Type
• Iodine-Deficiency Goitre
• Autoimmune Goitre (Hashimoto's, Graves')
• Multinodular Goitre
• Toxic Goitre
• Congenital Goitre

By Treatment Type
• Thyroid Hormone Replacement (Levothyroxine)
• Antithyroid Medications
• Iodine Supplementation
• Radioiodine Therapy
• Thyroid Surgery
• Nutritional & Lifestyle Management

By Diagnostic Method
• Thyroid Function Tests (TSH, T3, T4)
• Thyroid Antibody Panels
• Ultrasound
• Radionuclide Thyroid Scan
• FNAC (Biopsy)
• CT/MRI for Large or Retrosternal Goitres

By End User
• Hospitals
• Endocrinology Clinics
• Diagnostic Centers
• Specialty Thyroid Care Centers
• Research Institutions

By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/72019/goitre-market

Recent Developments
• Increasing adoption of high-resolution thyroid ultrasound for early detection.
• Development of improved levothyroxine formulations for precision dosing.
• Government initiatives supporting iodine supplementation in rural populations.
• Advances in minimally invasive thyroid surgery techniques.

Expert Quote - Irfan Tamboli, Business Development Executive
"Goitre remains a significant global health issue despite decades of nutritional intervention. With rising autoimmune thyroid disorders and improved diagnostic tools, the market is witnessing strong, sustained growth."

Conclusion
The Goitre Market will continue expanding through 2034 as iodine supplementation programs strengthen, autoimmune thyroid disorders rise, and diagnostic imaging technologies improve. Companies focusing on advanced thyroid therapeutics, nutraceuticals, imaging solutions, and endocrinology services are positioned for strong growth.

This report is also available in the following languages : Japanese (ゴイトレマーケット), Korean (갑상선종 시장), Chinese (甲状腺肿市场), French (Marché du goitre), German (Kropfmarkt), and Italian (Mercato del Gozzo), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72019

Related Reports

Cryopyrin-associated Periodic Syndromes Market
https://exactitudeconsultancy.com/reports/71077/cryopyrin-associated-periodic-syndromes-market

Familial Mediterranean Fever Market
https://exactitudeconsultancy.com/reports/71079/familial-mediterranean-fever-market

Homozygous Familial Hypercholesterolemia Patient Pool Market
https://exactitudeconsultancy.com/reports/71096/homozygous-familial-hypercholesterolemia-patient-pool-market

Progressive Familial Intrahepatic Cholestasis Market
https://exactitudeconsultancy.com/reports/71668/progressive-familial-intrahepatic-cholestasis-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.